Published on 28 Feb 2024 on Zacks via Yahoo Finance
Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.88 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -46.30%. A quarter ago, it was expected that this company would post a loss of $0.76 per share when it actually produced a loss of $0.71, delivering a surprise of 6.58%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.